Published on 27.01.2022

Lambda at Arab Health

We had an enriching time at Arab Health Exhibition 2022 in #Dubai, the largest and most important #Healthcare event of the Arab Region. For us it was the perfect opportunity to have plenty of promising talks to rehabilitation distributors from all around the world and also market companions. More good news coming soon, we are already looking forward to the next rehabilitation fairs with physical presence in 2022 and of course also the next edition of Arab Health in 2023!

In the same category


Canal Alpha's report highlighting our Lambda robots

We're proud to share Canal Alpha's recent report highlighting our Lambda robots and their positive impact on physiotherapy and physical therapy.

Watch the report to discover how our robots are revolutionizing the way we approach rehabilitation and offering new perspectives to patients in Switzerland and beyond. Many thanks to Canal Alpha for this great spotlight on our mission and hard work.

Read more

New Patent for Lambda !

The future belongs to those who know how to innovate!

It's here! A new patent that represents months of hard work by our talented team here at Lambda Health System. We're proud to see our commitment to research and development pay off.

This patent is a testament to our commitment to pushing the boundaries of innovation to deliver leading-edge mobility and rehabilitation solutions.
A huge thank you to our entire team for their dedication and ingenuity, and to our partners and collaborators for their ongoing support in this adventure!

Read more

Lambda demonstration at the NeuroReha Congress in Czech Republic

Lambda presents its latest advances at the NeuroReha Congress in Czech Republic !
Discover our new features: proprioception feedback, joint amplitude assessment and Progressive strength training.
Many thanks to all those who visited our stand and took part in our demonstrations!

Read more

Lambda Health System, partner of SWISSNEUROREHAB

SWISSNEUROREHAB is an interdisciplinary project to develop an innovative model for neurological rehabilitation.
Funding of CHF 11.2 million over the next five years, including CHF 5.9 million from Innosuisse, has just been secured.

The aim? To offer personalized care to patients with the after-effects of strokes, head injuries and paraplegia.


Read more